Financial News · Live Terminal

Caris Life Sciences Insider Sold Shares Worth $12,132,080, According to a Recent SEC Filing

Brian J Brille, Director, Vice Chairman and Executive Vice President, on September 17, 2026, sold 400,000 shares in Caris Life Sciences (CAI) for $12,132,080. Following the Form 4 filing with the SEC, Brille has control over a total of 730,303 common shares of the company, with 230,303 shares held directly and 500,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2019410/000207195926000008/xslF345X05/wk-form4_1789682909.xml

$CAI

Meta Platforms Insider Sold Shares Worth $13,504,556, According to a Recent SEC Filing

Christopher K Cox, Chief Product Officer, on September 15, 2026, sold 20,000 shares in Meta Platforms (META) for $13,504,556. Following the Form 4 filing with the SEC, Cox has control over a total of 279,562 Class A common shares of the company, with 279,562 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1326801/000095010326014140/xslF345X05/ownership.xml

$META

C3.ai Insider Sold Shares Worth $4,783,894, According to a Recent SEC Filing

Thomas M Siebel, 10% Owner, Director, Chief Executive Officer and Chairman of the Board, on September 15, 2026, sold 444,248 shares in C3.ai (AI) for $4,783,894. Following the Form 4 filing with the SEC, Siebel has control over a total of 9,316,701 Class A common shares of the company, with 722,362 shares held directly and 8,594,339 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1577526/000157752626000130/xslF345X05/wk-form4_1789685741.xml

$AI

CoreWeave Insider Sold Shares Worth $25,204,098, According to a Recent SEC Filing

Michael N Intrator, 10% Owner, Director, Chief Executive Officer and President, on September 15, 2026, sold 307,692 shares in CoreWeave (CRWV) for $25,204,098. Following the Form 4 filing with the SEC, Intrator has control over a total of 887,129 Class A common shares of the company, with 887,129 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1769628/000176962826000430/xslF345X05/form4.xml

$CRWV

FormFactor Insider Sold Shares Worth $1,833,817, According to a Recent SEC Filing

Mike Slessor, Director, Chief Executive Officer, on September 16, 2026, sold 17,510 shares in FormFactor (FORM) for $1,833,817. Following the Form 4 filing with the SEC, Slessor has control over a total of 466,694 common shares of the company, with 466,694 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1039399/000162828026062602/xslF345X05/wk-form4_1789687851.xml

$FORM

Nutanix Insider Sold Shares Worth $2,669,806, According to a Recent SEC Filing

Rukmini Sivaraman, Chief Financial Officer, on September 15, 2026, sold 38,139 shares in Nutanix (NTNX) for $2,669,806. Following the Form 4 filing with the SEC, Sivaraman has control over a total of 325,487 Class A common shares of the company, with 325,487 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1618732/000119312526394771/xslF345X05/ownership.xml

$NTNX

CrowdStrike Holdings Insider Sold Shares Worth $28,629,001, According to a Recent SEC Filing

Gerhard Watzinger, Director, on September 16, 2026, sold 120,000 shares in CrowdStrike Holdings (CRWD) for $28,629,001. Following the Form 4 filing with the SEC, Watzinger has control over a total of 189,680 Class A common shares of the company, with 34,116 shares held directly and 155,564 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1535527/000144583226000011/xslF345X05/form4-09172026_080903.xml

$CRWD

Palantir Technologies Insider Sold Shares Worth $2,762,292, According to a Recent SEC Filing

Alexander D. Moore, Director, on September 15, 2026, sold 16,000 shares in Palantir Technologies (PLTR) for $2,762,292. Following the Form 4 filing with the SEC, Moore has control over a total of 1,063,095 Class A common shares of the company, with 1,063,095 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1321655/000182395226000022/xslF345X05/wk-form4_1789692829.xml

$PLTR

Red Cat Holdings Insider Sold Shares Worth $1,161,000, According to a Recent SEC Filing

Jeffrey M Thompson, 10% Owner, Director, Chairman of the Board, Chief Executive Officer, on September 15, 2025, sold 150,000 shares in Red Cat Holdings (RCAT) for $1,161,000. Following the Form 4 filing with the SEC, Thompson has control over a total of 11,712,202 common shares of the company, with 11,712,202 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/748268/000149315226043191/xslF345X05/ownership.xml

$RCAT

Rubrik Insider Sold Shares Worth $1,048,108, According to a Recent SEC Filing

Kiran Kumar Choudary, Chief Financial Officer, on September 15, 2026, sold 10,000 shares in Rubrik (RBRK) for $1,048,108. Following the Form 4 filing with the SEC, Choudary has control over a total of 958,078 Class A common shares of the company, with 958,078 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1943896/000202022026000022/xslF345X05/form4-09182026_010913.xml

$RBRK

Travere Therapeutics Insider Sold Shares Worth $2,785,021, According to a Recent SEC Filing

Jula Inrig, Executive Vice President, Head of Research & Development & Chief Medical Officer, on September 15, 2026, sold 44,674 shares in Travere Therapeutics (TVTX) for $2,785,021. Following the Form 4 filing with the SEC, Inrig has control over a total of 100,491 common shares of the company, with 100,491 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000190236826000008/xslF345X05/form4-09182026_010947.xml

Travere Therapeutics Insider Sold Shares Worth $2,337,695, According to a Recent SEC Filing

Elizabeth E Reed, Chief Legal Officer and General Counsel, on September 15, 2026, sold 37,500 shares in Travere Therapeutics (TVTX) for $2,337,695. Following the Form 4 filing with the SEC, Reed has control over a total of 105,389 common shares of the company, with 105,389 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000128330326000010/xslF345X05/form4-09182026_010948.xml

Travere Therapeutics Insider Sold Shares Worth $25,390,729, According to a Recent SEC Filing

Eric M Dube, Director, Chief Executive Officer, on September 15, 2026, sold 400,000 shares in Travere Therapeutics (TVTX) for $25,390,729. Following the Form 4 filing with the SEC, Dube has control over a total of 432,886 common shares of the company, with 432,886 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000176349426000007/xslF345X05/form4-09182026_010928.xml

Travere Therapeutics Insider Sold Shares Worth $13,135,397, According to a Recent SEC Filing

William E. Rote, Chief Research Officer, on September 15, 2026, sold 209,048 shares in Travere Therapeutics (TVTX) for $13,135,397. Following the Form 4 filing with the SEC, Rote has control over a total of 98,197 common shares of the company, with 98,197 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000169826226000005/xslF345X05/form4-09182026_010952.xml

XP Insider Sold Shares Worth $2,413,865, According to a Recent SEC Filing

Bruno Constantino Alexandre Dos Santos, Director, on September 16, 2026, sold 123,257 shares in XP (XP) for $2,413,865. Following the Form 4 filing with the SEC, Dos Santos has control over a total of 1,500,000 Class A common shares of the company, with 1,500,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1787425/000095010326014163/xslF345X05/ownership.xml

$XP

Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing

Jon Faiz Kayyem, Director, on September 16, 2026, executed a purchase for 5,000 shares in Inhibrx Biosciences (INBX) for $500,000. Following the Form 4 filing with the SEC, Kayyem has control over a total of 1,069,046 common shares of the company, with 1,069,046 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2007919/000136626826000006/xslF345X05/wk-form4_1789681608.xml

$INBX

Cadence Design Systems Insider Sold Shares Worth $554,240, According to a Recent SEC Filing

Paul Cunningham, Senior Vice President, on September 15, 2026, sold 2,000 shares in Cadence Design Systems (CDNS) for $554,240. Following the Form 4 filing with the SEC, Cunningham has control over a total of 121,793 common shares of the company, with 121,793 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/813672/000081367226000100/xslF345X05/wk-form4_1789681310.xml

$CDNS

908 Devices Insider Sold Shares Worth $280,070, According to a Recent SEC Filing

John Kenneweg, Senior Vice President, Sales & Product Marketing, on September 15, 2026, sold 27,656 shares in 908 Devices (MASS) for $280,070. Following the Form 4 filing with the SEC, Kenneweg has control over a total of 57,784 common shares of the company, with 57,784 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1555279/000183687626000011/xslF345X05/form4-09172026_090941.xml

$MASS